Heritage Bio Labs
Research Library
Explore 411 articles about peptides, research compounds and related topics, with links to the original studies.
Find articles
All articles
Showing 337–348 of 411 articles
- Check methods and identity
How to Read a Semax Brain Imaging Result in Healthy Volunteers
Semax is a synthetic seven-amino-acid peptide. An older imaging study compared Semax, Selank and placebo in healthy volunteers. This direct study measured brain connectivity over a short interval rather than showing whether cognition or daily function improved.
Semax1 source (2020)
- Explore study findings
What the Interim Compounding Policy Actually Covers for Semax
Semax is a synthetic seven-amino-acid peptide. In 2026, FDA and HHS documents discussed specific Semax-related bulk substances. These sources explain a regulatory context, not a finding that Semax improves memory or recovery.
Semax3 sources (2026)
- Check methods and identity
Why a urine test measures both sermorelin and a breakdown product
Sermorelin is the synthetic, amidated version of the first 29 residues of human growth hormone–releasing hormone (GHRH). An analytical study asked how to distinguish this peptide and a breakdown product from related substances in urine.
Sermorelin2 sources (2013, 2025)
- Explore study findings
What the FDA's Geref records say about its former indications
Sermorelin is a synthetic 29-residue fragment of human growth hormone–releasing hormone, with an amidated end. The history of Geref, a U.S. sermorelin acetate product, shows how a diagnostic approval and a treatment approval can address separate questions.
Sermorelin2 sources (1996, 2013)
- Check methods and identity
How an older HIV study measured changes in body composition
Sermorelin is a synthetic version of the first 29 amino acids of growth hormone–releasing hormone (GHRH). A human trial asked whether the older Geref product changed hormone and body composition measurements in men with HIV-associated lipodystrophy.
Sermorelin2 sources (2004, 2013)
- Understand the science
Why a releasing signal produced different growth hormone responses after radiation
Sermorelin is the amidated first 29 residues of growth hormone–releasing hormone (GHRH), prepared as a synthetic peptide.
Sermorelin2 sources (1999, 2013)
- Check methods and identity
What a year of height measurements showed in a pediatric study
Sermorelin is a synthetic 29-residue fragment of human growth hormone–releasing hormone. In an older multicenter study, researchers asked whether children with growth hormone deficiency grew faster over the first year while receiving the fragment.
Sermorelin2 sources (1996, 2013)
- Interpret the evidence
How researchers separated peptide absorption from a hormone response
Sermorelin is an amidated 29-amino-acid fragment of human growth hormone–releasing hormone (GHRH). An early study in volunteers compared how much of this fragment reached blood and how long the downstream hormone response lasted under different experimental conditions.
Sermorelin2 sources (1993, 2013)
- Explore study findings
What human liver fractions revealed about SLU-PP-332 breakdown
SLU-PP-332 is a small synthetic compound with a different chemical structure from a peptide. It activates a group of proteins called estrogen-related receptors. In 2026, two laboratories examined what happened to the compound when exposed to enzymes prepared from human liver tissue.
SLU-PP-3323 sources (2023, 2026)
- Understand the science
How chemists used SLU-PP-332 to design related compounds
SLU-PP-332 is a small nonpeptide molecule that activates estrogen-related receptors, or ERRs. A 2026 study used its chemical structure as a starting point and asked which changes affected receptor signaling and properties such as solubility.
SLU-PP-3321 source (2026)
- Explore study findings
Why SLU-PP-915 results belong to a different compound
SLU-PP-332 is a synthetic small molecule outside that class. It acts on estrogen-related receptors, which help regulate genes involved in energy metabolism. A recent animal study compared it with another small molecule called SLU-PP-915 and examined which effects were shared.
SLU-PP-3321 source (2025)
- Check methods and identity
What an older mouse study measured about fat as fuel
SLU-PP-332 is a synthetic nonpeptide activator of estrogen-related receptors. An older study tested what happened to energy use and body composition in two mouse models of obesity and metabolic dysfunction. One model used diet to induce obesity.
SLU-PP-3321 source (2024)
Browse by product
- A4 Amyloid Beta6 articles
- ACE-0316 articles
- ACE-0836 articles
- Adipotide6 articles
- AICAR6 articles
- AOD-96046 articles
- ARA-2906 articles
- BPC-1576 articles
- BPC-157 / TB-5006 articles
- Cagrilintide7 articles
- CJC-1295 (No DAC) / GHRP-26 articles
- CJC-1295 (No DAC) / GHRP-66 articles
- CJC-1295 (No DAC) / Ipamorelin6 articles
- CJC-1295 No DAC6 articles
- CJC-1295 With DAC6 articles
- DSIP6 articles
- Epitalon6 articles
- Follistatin 3156 articles
- Follistatin 3446 articles
- Fragment 176-1916 articles
- GHK-Cu6 articles
- GHRP-26 articles
- GHRP-66 articles
- GLOW 2 Blend6 articles
- GLOW Blend6 articles
- GLP-1 SEMA6 articles
- GLP-2 TIRZ6 articles
- Glutathione6 articles
- HCG6 articles
- Hexarelin6 articles
- Human Relaxin-26 articles
- IGF-1 DES 1,36 articles
- IGF-1 Human6 articles
- IGF-2 LR36 articles
- IGF-DES 1,36 articles
- IGF-LR36 articles
- Ipamorelin6 articles
- Kisspeptin-106 articles
- KLOW Blend6 articles
- KPV6 articles
- Lipopeptide6 articles
- Liraglutide6 articles
- Melanotan II5 articles
- MGF6 articles
- MOTS-C6 articles
- MSC Exosomes6 articles
- Myostatin6 articles
- Myostatin HMP (GDF8)6 articles
- Oxytocin7 articles
- PEG-MGF6 articles
- Pinealon6 articles
- PT-1416 articles
- RETA / IGF-1 LR36 articles
- RETA GLP-36 articles
- Selank6 articles
- SEMA / IGF-1 LR36 articles
- Semax6 articles
- Sermorelin6 articles
- SLU-PP-3326 articles
- SNAP-86 articles
- Survodutide7 articles
- TB-5006 articles
- Tesamorelin6 articles
- Thymosin Alpha-16 articles
- TIRZ / IGF-1 LR36 articles
- TIRZ GLP-26 articles
- Trevogrumab6 articles
- Triptorelin GnRH6 articles
